title: Are NMDA receptor antagonists beneficial in the treatment of schizophrenia?
authors.affiliation: Rosalind Franklin University of Medicine and Science (RFUMS), The Chicago Medical School, United States. Electronic address: seong.shim@va.gov.
authors.forename: Seong S
authors.initials: SS
authors.lastname: Shim
authors.affiliation: Rosalind Franklin University of Medicine and Science (RFUMS), The Chicago Medical School, United States.
authors.forename: Rashid
authors.initials: R
authors.lastname: Nadeem
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate
keywords: Amantadine; Cognitive symptoms; Memantine; Meta-analysis; NMDA receptor antagonists; Schizophrenia